Peginterferon lambda-1a

Generic Name: Peginterferon lambda-1a

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: 914617-98-4

Unique Ingredient Identifier: 0T0250N43U

Background: Peginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

Phase 3

Conditions: Sars-CoV2
Covid19

Interventions: Drug: Peginterferon Lambda-1A
Other: Placebo

First Posted Date: 2021-07-19

Last Posted Date: 2022-04-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 763

Registration Number: NCT04967430

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19

Phase 2

Completed

Conditions: Sars-CoV2
Covid-19

Interventions: Other: placebo
Drug: Peginterferon Lambda-1A

First Posted Date: 2020-04-21

Last Posted Date: 2023-12-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 157

Registration Number: NCT04354259

Locations: 🇨🇦
University of Calgary, Calgary, Alberta, Canada
🇧🇷
Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil
🇧🇷
Hospital das Clínicas São Paulo, Sao Paulo, Brazil

and more 4 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy